“So, whilst GSK are keeping the same name, we wanted to bring to life the company’s ‘Ahead Together’ purpose, which is all about innovation through collaboration. The new logo helps to do this by ...
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback